Business
Johnson & Johnson single-dose vaccine shown to be effective against COVID-19 – ABC News
The single-shot option is not as strong as some of its two-shot rivals, however it could be potentially helpful for a world in dire need of more doses.
Johnson & Johnson’s (J&J) vaccine candidate appears to protect against COVID-19 with just one shot of the dose.
Key points:
- Johnson & Johnson says trial results show its one-shot vaccine is 66 per cent effective against COVID-19
- While promising, it is still behind many rivals who are using a two-shot vaccine
- The company says trying to create a vaccine which requires one shot is worthwhile as the virus continues to spread
The single-shot option is not as strong as some of its two-shot rivals, however…
Continue Reading
-
Business21 hours agoWhere will Berkshire Hathaway be in 1 year?
-
Noosa News24 hours agoPolice reject claims about detained protester; SEQ train lines to be disrupted; BlueCare to cut enrolled nurses
-
Noosa News23 hours agoNick Cave and The Bad Seeds Are Bringing Their ‘Wild God’ Tour to Australia and New Zealand in 2026
-
Business23 hours agoWhat’s Bell Potter’s take on Endeavour Group shares following earnings results?